Target intelligence / Profile preview

Host vaginal epithelial cell lipids and proteins

Molecular classification
Other, Receptor
01

Overview

The host vaginal epithelial cell lipids and proteins constitute the complex molecular architecture of the vaginal mucosal surface, serving as the primary interface between the host and the external environment (NIH, 2017). This target encompasses the lipid bilayer of the plasma membrane, including specialized microdomains like lipid rafts, as well as a diverse array of surface proteins such as receptors, adhesion molecules, and transporters (NIH, 2005). Biologically, these components maintain the structural integrity of the vaginal barrier and facilitate interactions with the vaginal microbiota, particularly beneficial Lactobacillus species (ResearchGate, 2023). In the context of disease, this surface is the initial site of attachment and entry for various pathogens, including HIV-1, Candida albicans, and Neisseria gonorrhoeae (PLoS ONE, 2014). Pharmacologically, it is the target for topical agents such as surfactants (e.g., Nonoxynol-9) that disrupt membrane lipids for spermicidal and microbicidal effects (DrugBank). It is also the site of action for polyanionic microbicides that bind to surface proteins to block viral entry (NIH, 2015). However, therapeutic manipulation of this target carries significant safety challenges, as disruption of the epithelial membrane can lead to inflammation and paradoxically increase the risk of infection (PLoS ONE, 2021).

Other names
Vaginal epithelial cell membraneVaginal mucosal surfaceVaginal epithelial cell surfaceHost cell surface lipids and proteins
02

Mechanism of action

Membrane disruption and competitive binding to surface molecules

03

Biological functions

Barrier functionImmune responseCell-cell communicationPathogen adherence
04

Disease associations

InfectionInflammationVaginal atrophy
05

Safety considerations

Mucosal irritationIncreased risk of HIV transmissionDisruption of vaginal microbiota
06

Interacting drugs

Nonoxynol-9

4 more in the full profile.

07

Biomarkers

Lactate dehydrogenase (LDH)Interleukin-1 alpha (IL-1α)Interleukin-8 (IL-8)Transepithelial electrical resistance (TEER)

Beyond the preview

Go deeper on Host vaginal epithelial cell lipids and proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host vaginal epithelial cell lipids and proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call